Skip to content

Mativ Holdings stock

MATVNYSE

Mativ Holdings, Inc., Basic MaterialsISIN US8085411069

$12.01▼ $0.37 (−3.0%)Closing price of 12 Nov 2026

55Score 55 out of 100, Neutral

Turn on early warning

Price and trend

87 / 100

Price history

−9.1% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 17% above it.

Trend change

Since September 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 49).

Distance to the high

The price is 20% below its 52-week high. Largest decline in 20 years: 93% (October 2013 to April 2025).

Chart figures for advanced users
SMA 50$11.90
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$10.25
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)49
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$7.22
The lowest closing price of the last twelve months.
Resistance$15.05
The highest closing price of the last twelve months.
Market cap
$662.86M
Div. yield
3.33%
12 months
7.2
includes one-off items, adjusted 11.8
Fair value
$16.85

Snapshot

Computed from the data by fixed rules, no AI

  • Mativ Holdings, Inc. belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $662.86M, is number 95 of 106 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $1.99B (up 0.3% year on year) and a loss of $337.4M.
  • MEQIRI Score 55 out of 100 (Neutral): rank 261 of 461 in Basic Materials, median 57.
Show more
  • Our model puts fair value at $16.85, with the price 29% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Growing faster than its industryRevenue up 23.4% a year since 2020, Chemicals (Specialty) median 6%.
  • Earnings turn into cashFree cash flow 137% of earnings over the last 12 months.Fundamentals 65
  • High dividend yieldDividend yield 3.33%, Chemicals (Specialty) median 1.97%.

Weaknesses

  • DilutionShare count up 77% since 2020.Capital allocation 24
  • High debtDebt 2.24 times equity (latest quarter), Chemicals (Specialty) median 0.63.Stability 32
  • Turned to a lossEarnings per share from $2.68 in 2020 to −$6.19.Growth 49
55/ 100
MEQIRI Score
Neutral

Its standout strengths are technical analysis and valuation, while stability and capital allocation hold the score back.

Daily figure as of 13 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 56 to 55.

The fundamentals are in the middle range.

Profit consistency60% of years
Cash conversion (free cash flow to earnings, 12 months)137%
ROIC (12 months)4.1%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • cyclical sector (energy or materials), as a group, crashed more often in the backtest
  • high price swings

Valuation

Valuation signal

Possible value trap
Price
$12.01
Fair value
$16.85
Gap to fair value
−29%

In our model the price counts as cheap below $12.04 and expensive above $28.09 (uncertainty high, based on the price swings of the past year).

Calculated with a cost of equity of 11.9%. At 12.9% the fair value would be $15.01, at 10.9% it would be $19.21.

Possible value trap: looks cheap, but high risk.

Valuation metrics

0.68
9.8
Fair value (model)
$16.85

From the cash-flow model alone; the profit includes one-off items, so there is no industry value.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue fell 0.4% on the twelve months before. Up to 2020 the bars include businesses that were later spun off or sold. On a comparable basis, as restated in the SEC annual reports, revenue grew 23.4% a year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 15%, operating 2%, net −17%. Last 12 months: net 5%.

Debt & balance sheet

latest quarter
2.24
−5.5x
1.93
Cash & equivalents
$97.3M

Debt is elevated. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
17 Feb 2027in 96 days
Last reported
4 Nov 2026EPS reported $0.31 (expected $0.25)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20261 analyst
Earnings per share
$0.970.0%
Revenue
$2.02B0.0%
Fiscal 20271 analyst
Earnings per share
$1.250.0%
Revenue
$2.09B0.0%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook lowered

Share price after the results: −0.8%

Second quarter adjusted EBITDA is expected to fall by a mid single digit percentage; 2026 raw material inflation is now estimated at $40 million to $50 million, up from $20 million to $25 million.

Supporting passage from the call, verbatim
“Coming into 2026, we estimated full year raw material inflation to be $20 million to $25 million across our basket of purchases with increases weighing more heavily on the second half of the year. We took pricing action in January to fully offset this inflation within 2026.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 7 May 2026 (fiscal Q1 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases or sales in the last 6 months.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Mativ Holdings

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

461 rated companies in Basic Materials

Rank 261 of 461
261/ 461
This company
55
Sector median
57

Categories against the sector median

ProfitabilityMedian of 461 companies44 (median 49)5 below the median
GrowthMedian of 461 companies49 (median 54)5 below the median
FundamentalsMedian of 461 companies65 (median 65)0 at the median
ValuationMedian of 421 companies with a value83 (median 69)14 above the median
StabilityMedian of 461 companies32 (median 67)35 below the median
Capital allocationMedian of 461 companies24 (median 52)28 below the median
Technical analysisMedian of 461 companies87 (median 51)36 above the median
MomentumMedian of 461 companies65 (median 50)15 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Chemicals (Specialty)

The next larger and next smaller companies by market value

All 106 Chemicals (Specialty) stocks

ETFs that hold Mativ Holdings

Held by 3 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
WisdomTree US High Dividend UCITS ETF AccWTD90.04%0.29%€182.46M
WisdomTree US Equity Income UCITS ETF EUR Hedged AccWTDY0.04%0.35%€204.34M

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy